Literature DB >> 22456982

Effect of reactivity on cellular accumulation and cytotoxicity of oxaliplatin analogues.

Irina Buß1, Ganna V Kalayda, Andreas Lindauer, Michael R Reithofer, Markus Galanski, Bernhard K Keppler, Ulrich Jaehde.   

Abstract

The purpose of this study was to systematically investigate the relationships between reactivity, cellular accumulation, and cytotoxicity of a panel of oxaliplatin analogues with different leaving groups in human carcinoma cells. The reactivity of the complexes towards the nucleotides 2'-deoxyguanosine 5'-monophosphate and 2'-deoxyadenosine 5'-monophosphate was studied using capillary electrophoresis. Cellular accumulation and cytotoxicity were measured in an oxaliplatin-sensitive and oxaliplatin-resistant ileocecal colorectal adenocarcinoma cell line pair (HCT-8/HCT-8ox). Platinum concentrations were determined by flameless atomic absorption spectrometry. The 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay was used to assess cytotoxicity. Early cellular platinum accumulation was predominantly affected by lipophilicity. A relationship between reactivity and cellular accumulation was observed for three of four platinum complexes investigated, whereas the most lipophilic oxaliplatin analogue was an exception. Increased reactivity and reduced lipophilicity were associated with high cytotoxic activity. Resistance was influenced by lipophilicity but not by reactivity. The observed relationships may help in the design of analogues with high antitumoral activity in oxaliplatin-sensitive as well as oxaliplatin-resistant cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22456982     DOI: 10.1007/s00775-012-0889-9

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  38 in total

Review 1.  The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy.

Authors:  Matthew D Hall; Mitsunori Okabe; Ding-Wu Shen; Xing-Jie Liang; Michael M Gottesman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

Review 2.  Resistance to cisplatin.

Authors:  S Akiyama; Z S Chen; T Sumizawa; T Furukawa
Journal:  Anticancer Drug Des       Date:  1999-04

3.  Organic cation transporters are determinants of oxaliplatin cytotoxicity.

Authors:  Shuzhong Zhang; Katherine S Lovejoy; James E Shima; Leah L Lagpacan; Yan Shu; Anna Lapuk; Ying Chen; Takafumi Komori; Joe W Gray; Xin Chen; Stephen J Lippard; Kathleen M Giacomini
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

4.  Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2.

Authors:  Giuliano Ciarimboli; Thomas Ludwig; Detlef Lang; Hermann Pavenstädt; Hermann Koepsell; Hans-Jürgen Piechota; Jörg Haier; Ulrich Jaehde; Jochen Zisowsky; Eberhard Schlatter
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

5.  Mitochondria in platinum resistant cells.

Authors:  S Isonishi; M Saitou; M Yasuda; T Tanaka
Journal:  Hum Cell       Date:  2001-09       Impact factor: 4.174

6.  Determination of platinum complexes in clinical samples by a rapid flameless atomic absorption spectrometry assay.

Authors:  C Kloft; H Appelius; W Siegert; W Schunack; U Jaehde
Journal:  Ther Drug Monit       Date:  1999-12       Impact factor: 3.681

7.  Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin.

Authors:  Alison K Holzer; Gerald H Manorek; Stephen B Howell
Journal:  Mol Pharmacol       Date:  2006-07-17       Impact factor: 4.436

8.  Cisplatin stabilizes a multimeric complex of the human Ctr1 copper transporter: requirement for the extracellular methionine-rich clusters.

Authors:  Yan Guo; Kathryn Smith; Michael J Petris
Journal:  J Biol Chem       Date:  2004-08-23       Impact factor: 5.157

9.  Kinetic study on the reactions of platinum drugs with glutathione.

Authors:  Douglas Hagrman; Jerry Goodisman; Abdul-Kader Souid
Journal:  J Pharmacol Exp Ther       Date:  2003-11-10       Impact factor: 4.030

10.  The impact of different chelating leaving groups on the substitution kinetics of mononuclear Pt(II)(1,2-trans-R,R-diaminocyclohexane)(X-Y) complexes.

Authors:  Nadine Summa; Tanja Soldatović; Lutz Dahlenburg; Zivadin D Bugarcić; Rudi van Eldik
Journal:  J Biol Inorg Chem       Date:  2007-01-24       Impact factor: 3.862

View more
  3 in total

1.  Upregulated OCT3 has the potential to improve the survival of colorectal cancer patients treated with (m)FOLFOX6 adjuvant chemotherapy.

Authors:  Juan Gu; Dandan Dong; Enwu Long; Shiwei Tang; Suqin Feng; Tingting Li; Ling Wang; Xuehua Jiang
Journal:  Int J Colorectal Dis       Date:  2019-11-16       Impact factor: 2.571

2.  A Potent Glucose-Platinum Conjugate Exploits Glucose Transporters and Preferentially Accumulates in Cancer Cells.

Authors:  Malay Patra; Timothy C Johnstone; Kogularamanan Suntharalingam; Stephen J Lippard
Journal:  Angew Chem Int Ed Engl       Date:  2016-01-08       Impact factor: 15.336

3.  Transporter-Mediated Interaction Between Platinum Drugs and Sorafenib at the Cellular Level.

Authors:  Verena Schneider; Selim Chaib; Claudia Spanier; Mandy Knapp; Violeta Moscvin; Laura Scordovillo; Alessandra Ewertz; Ulrich Jaehde; Ganna V Kalayda
Journal:  AAPS J       Date:  2017-11-30       Impact factor: 4.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.